| Literature DB >> 34217155 |
Fatemeh Zandi1,2, Fatemeh Goshadrou2, Anna Meyfour3,4, Behrouz Vaziri1.
Abstract
Viruses are obligatory intracellular parasites that use cell proteins to take the control of the cell functions in order to accomplish their life cycle. Studying the viral-host interactions would increase our knowledge of the viral biology and mechanisms of pathogenesis. Studies on pathogenesis mechanisms of lyssaviruses, which are the causative agents of rabies, have revealed some important host protein partners for viral proteins, especially for most studied species, i.e. Rabies virus. In this review article, the key physical lyssavirus-host protein interactions, their contributions to rabies infection, and their exploitation are discussed to improve the knowledge about rabies pathogenesis.Entities:
Keywords: Host-Pathogen Interactions; Lyssavirus; Rabies
Mesh:
Year: 2021 PMID: 34217155 PMCID: PMC8334389 DOI: 10.52547/ibj.25.4.226
Source DB: PubMed Journal: Iran Biomed J ISSN: 1028-852X
Fig. 1Lyssavirus life cycle in the neuron. Following the attachment of G protein to the neuronal receptors, virus enters the cell through endocytosis (step 1). Virion is then transported within the vesicle along axonal MTs (step 2) and is uncoated in the cell body, releasing the RNP complex (step 3). The encapsidated RNA genome is transcribed to form five mRNAs related to structural genes (step 4), which are then translated into the viral proteins, namely N, P, M, G, and L (step 5). The genome is also transcribed to form the anti-genome, which is a positive-strand intermediate RNA and is used as a template for the replication of genome (step 6). Subsequently, assembly of the viral components (step 7), budding (step 8), and release (step 9) of the virion are achieved
Fig. 2Overview of the validated physical interactions between lyssavirus G and host proteins. Host partners are colored in dark blue. Downstream signaling (if elucidated) and/or functional/pathologic outcomes of PPIs are shown. X represents a cellular ligand, and P in black circle stands for a phosphate. Interaction: , Stimulation: , Inhibition: , Outcome: .
Fig. 3Overview of the validated physical interactions between lyssavirus N, lyssavirus L and host proteins. Host partners are colored in dark blue. Downstream signaling (if elucidated) and/or functional/pathologic outcomes of PPIs are represented. Interaction: , Stimulation: , Outcome: , Upregulation:
Fig. 4Overview of the validated physical interactions between lyssavirus P and host proteins. Host partners are colored in dark blue. Downstream signaling (if elucidated) and/or functional/pathologic outcomes of PPIs are represented. Blockage of an outcome is represented by a red cross. P in green and black circles stands for RABV phosphoprotein and a phosphate, respectively. Interaction: , Stimulation: , Inhibition: , Outcome: , Upregulation:, Translocation Inhibition: .
Fig. 5Overview of the validated physical interactions between lyssavirus M and host proteins. Host partners are colored in dark blue. Downstream signaling (if elucidated) and/or functional/pathologic outcomes of PPIs are represented. Blockage of an outcome is represented by a red cross. P in green and black circles stands for RABV phosphoprotein and a phosphate, respectively. Interaction: , Stimulation: , Inhibition: , Outcome: , Downregulation:, Translocation Stimulation: .
List of the prominent experimentally defined lyssavirus-host PPIs retrieved by literature and virus-host interaction databases mining
|
|
|
|
|
|---|---|---|---|
| G | RABV (CVS strain) | nAChR | Colocalization[[ |
| G | RABV (CVS strain) | NCAM | Binding inhibition assay, Virus neutralization[[ |
| G | RABV (street strain) | p75NTR | Screening of the cDNA library, Co-IP[[ |
| G | RABV (ERA strain, CVS-24 strain & street virus GX/09), WCBV | mGluR2 | RNAi strategy, Co-IP, Pull-down assay[[ |
| G | RABV (Virulent strains) | MAST1,2 | Yeast-two hybrid assay[[ |
| G | RABV (Attenuated strains) | PTPN4 | Yeast-two hybrid assay[[ |
| G | RABV (CVS-11, SAD strains) | SNAP25 | Colocalization, Co-IP[[ |
| N | RABV (CVS strain) | HSP70 | Immunoaffinity column immobilized with anti-N[[ |
| N | RABV (HEP-Flury strain) | (CCTγ) | Colocalization, RNAi strategy[[ |
| N | RABV (HEP-Flury strain) | PFDN1 | Colocalization[[ |
| L | RABV (SAD B19 strain) | DLC1 | Colocalization, Mutation in DLC1 motif[[ |
| M | RABV | NEDD4 | GST fusion proteins, Far-western blot assay[[ |
| M | RABV | YAP1 | Far-western blot assay[[ |
| M | RABV (PV strain) | eIF3h | Yeast-two hybrid assay, |
| M | MOKV | Cco1 | Yeast-two hybrid assay, Co-IP, Colocalization[[ |
| M | RABV (Thailand, SAD B19, PV strains), MOKV, LBV, EBLV-1) | RelAp43 | Yeast-two hybrid assay, Co-IP[[ |
| M | RABV (a street strain) | JAK1 | Protein complementation assay[[ |
| M | RABV (a street strain) | STAT1 | Protein complementation assay[[ |
| M | RABV (ERA strain) | ATP6V1A | Co-IP, Pull-down assay[[ |
| P | RABV (CVS-11 strain), MOKV | DLC1,2 | Yeast-two hybrid assay[[ |
| P, P3 isoform | RABV (CVS strain) | PML | Co-IP, Colocalization[[ |
| P | RABV (SAD l16, CVS, SHBRV strains), MOKV, ABLV | STAT1,2 | Yeast-two hybrid assay[[ |
| P | RABV (CVs strain) | STAT3 | Co-IP, Colocalization[[ |
| P (P3 Isoform) | RABV (CVSII strain) | TUB α/β | Colocalization, Biochemical test[[ |
| P | RABV (HEP-Flury strain) | CCTγ | Colocalization, RNAi strategy[[ |
| P (P3 isoform) | RABV (CVS-11strain) | NCL | Co-IP, Colocalization[[ |
| P | RABV (CVS, 8743THA, Ni, Ni-CE strains), ABLV | FAK | Yeast two-hybrid assay, Co-IP[[ |
| P | RABV (CVS-11 strain) | Mitochondrial complex I | Co-IP, Colocalization[[ |
| P | RABV (street strains 1088 and HCM-9) | IKKε | Co-IP[[ |
| P | RABV (SAD L16 strain) | Rpl9 | Phage display assay, Co-IP, Pull-down assay[[ |
| P (P3 Isoform) | RABV (Ni strain) | MT | Colocalization, |
| P | RABV (HEP-Flury, CVS-11 strains) | HSP90AA1/Cdc37 | Co-IP, colocalization[[ |
| P | RABV (street strain 8743THA) | JAK1 | Protein complementation assay[[ |
| P, P5 isoform | RABV (HEP-Flury, CVS-11 strains) | BECN1 | Co-IP, Colocalization[[ |
| P | RABV (ERA strain) | ABCE1 | Pull-down assay, Co-IP[[ |
| P | RABV (CVS-B2c, DRV-Mexico) | IIGP1 | Co-IP, Colocalization[[ |
Fig. 6.Experimentally identified and validated interactions between five proteins of lyssavirus including G (glycoprotein), N (nucleoprotein), L (RNA-dependent polymerase), P (phosphoprotein), and M (matrix protein) in colored nodes and host proteins in non-colored nodes is represented
Fig. 7The lyssavirus-host experimentally defined PPIs and their functional/pathologic outcomes in rabies infection indicated in a neuron. G (glycoprotein), N (nucleoprotein), L (RNA-dependent polymerase or Large protein), P (phosphoprotein), and M (matrix protein) represent five viral proteins which interact with host proteins and facilitate receptor mediated entry of lyssavirus (a), uncoating (b), viral transcription/translation/replication (c), viral protein folding (d), neuronal survival/death (e), immuno-regulation (f), mitochondrial dysfunction (g), membrane fusion (h), and budding (i) during infection. Contribution of the identified PPIs in the mentioned processes has been displayed in the figure and explained in the text. The association of viral-host proteins is shown by right-leftwards arrows in black